Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical Trials

Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical Trials Health Canada is requesting sponsor participation in the Regulatory Enrolment Process (REP) non-functional pilot for clinical trial regulatory activities. REP is a method Health Canada uses to collect information from sponsors related to their company, dossiers, products, regulatory activities and transactions. 2020-05-01 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyDrug productRegulatory Enrolment Process (REP)clinical trial Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical TrialsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-enrolment-process/updated-notice-non-functional-pilot-clinical-trials.html Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical TrialsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/processus-inscription-reglementaire/avis-mise-a-jour-projet-pilote-non-fonctionnel-essais-cliniques.html

Health Canada is requesting sponsor participation in the Regulatory Enrolment Process (REP) non-functional pilot for clinical trial regulatory activities. REP is a method Health Canada uses to collect information from sponsors related to their company, dossiers, products, regulatory activities and transactions.

Data and Resources

Similar records